CY1110821T1 - Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης - Google Patents

Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης

Info

Publication number
CY1110821T1
CY1110821T1 CY20101100894T CY101100894T CY1110821T1 CY 1110821 T1 CY1110821 T1 CY 1110821T1 CY 20101100894 T CY20101100894 T CY 20101100894T CY 101100894 T CY101100894 T CY 101100894T CY 1110821 T1 CY1110821 T1 CY 1110821T1
Authority
CY
Cyprus
Prior art keywords
tetraydrokinoline
pagagones
antibakthpiakoi
tricyclic
tetrahydroquinoline
Prior art date
Application number
CY20101100894T
Other languages
English (en)
Inventor
M R Barbachyn
P J Dobrowolski
A R Hurd
D J Mcnamara
John Raymond Palmer
A G Romero
James Craig Ruble
D A Sherry
L M Thomasco
P L Toogood
Gordon L Bundy
Gary E Martin
Donna L Romero
Original Assignee
Pharmacia & Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Llc filed Critical Pharmacia & Upjohn Company Llc
Publication of CY1110821T1 publication Critical patent/CY1110821T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η εφεύρεση περιλαμβάνει την τετραϋδροκινολίνη και τις συγγενείς ενώσεις του τύπου (I), και φαρμακευτικές συνθέσεις τους, που επιδεικνύουν χρήσιμη αντιβακτηριακή δραστικότητα ενάντια σε μια ευρεία κλίμακα ανθρώπινων και κτηνιατρικών παθογόνων.
CY20101100894T 2002-10-07 2010-10-06 Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης CY1110821T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41668502P 2002-10-07 2002-10-07
US42718902P 2002-11-18 2002-11-18
US45762203P 2003-03-26 2003-03-26
EP03799056A EP1551849B1 (en) 2002-10-07 2003-10-03 Tricyclic tetrahydroquinoline antibacterial agents

Publications (1)

Publication Number Publication Date
CY1110821T1 true CY1110821T1 (el) 2015-06-10

Family

ID=32074379

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100894T CY1110821T1 (el) 2002-10-07 2010-10-06 Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης

Country Status (16)

Country Link
US (4) US7208490B2 (el)
EP (1) EP1551849B1 (el)
JP (1) JP4009652B2 (el)
AR (1) AR041546A1 (el)
AT (1) ATE473985T1 (el)
AU (1) AU2003264768A1 (el)
BR (1) BR0315139A (el)
CA (1) CA2500824C (el)
CY (1) CY1110821T1 (el)
DE (1) DE60333379D1 (el)
DK (1) DK1551849T3 (el)
MX (1) MXPA05002701A (el)
PT (1) PT1551849E (el)
SI (1) SI1551849T1 (el)
TW (1) TWI295671B (el)
WO (1) WO2004031195A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
JP2008543739A (ja) * 2005-05-09 2008-12-04 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌剤
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
KR20100046165A (ko) * 2007-07-02 2010-05-06 아스트라제네카 아베 3-스피로피리미딘트리온-퀴놀린 유도체 및 항박테리아제로서의 이들의 용도
KR20100066439A (ko) 2007-07-16 2010-06-17 아스트라제네카 아베 항균제로서 사용하기 위한 스피로 축합 바르비투르산 유도체
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
JP5749169B2 (ja) * 2008-10-14 2015-07-15 アストラゼネカ アクチボラグ 細菌感染の処置用の縮合スピロ環式ヘテロ芳香族化合物
CA2740195A1 (en) * 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
CR20180412A (es) 2010-07-16 2018-11-01 Abbvie Ireland Unlimited Co Proceso para preparar compuestos antivirales
EP2593226B1 (en) 2010-07-16 2018-11-14 AbbVie Ireland Unlimited Company Phosphine ligands for catalytic reactions
WO2014042647A1 (en) * 2012-09-14 2014-03-20 Levina Elizabeth Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
US8952149B2 (en) * 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) * 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
CN108101860B (zh) * 2018-02-08 2021-11-23 苏州敬业医药化工有限公司 顺式-2，6-二甲基吗啉的制备方法
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
CA2425283A1 (en) 2000-10-26 2002-05-02 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO2003091252A1 (en) 2002-04-25 2003-11-06 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
US7105547B2 (en) 2002-10-10 2006-09-12 Pharmacia And Upjohn Company Antimicrobial 1-aryl dihydropyridone compounds

Also Published As

Publication number Publication date
AU2003264768A1 (en) 2004-04-23
JP2006511595A (ja) 2006-04-06
MXPA05002701A (es) 2005-08-19
US20100022524A1 (en) 2010-01-28
US7208490B2 (en) 2007-04-24
CA2500824A1 (en) 2004-04-15
SI1551849T1 (sl) 2010-11-30
US20070161630A1 (en) 2007-07-12
BR0315139A (pt) 2005-08-09
US20040162279A1 (en) 2004-08-19
DE60333379D1 (de) 2010-08-26
EP1551849B1 (en) 2010-07-14
AR041546A1 (es) 2005-05-18
ATE473985T1 (de) 2010-07-15
US20110092494A1 (en) 2011-04-21
EP1551849A1 (en) 2005-07-13
CA2500824C (en) 2011-03-22
JP4009652B2 (ja) 2007-11-21
WO2004031195A1 (en) 2004-04-15
DK1551849T3 (da) 2010-10-25
TW200413394A (en) 2004-08-01
TWI295671B (en) 2008-04-11
PT1551849E (pt) 2010-09-27
US8420646B2 (en) 2013-04-16
US7605157B2 (en) 2009-10-20

Similar Documents

Publication Publication Date Title
CY1110821T1 (el) Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης
CY1116784T1 (el) Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1105705T1 (el) Παραγωγα ινδολυλαλκυλαμινης σαν συνδετηρες 5-υδροξυτρυπταμινης-6
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1112630T1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
CY1107503T1 (el) Αντιβιοτικα διπλης δρασης
CY1119488T1 (el) Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
CY1111246T1 (el) Προληψη και θεραπεια επαγομενης απο φλεγμονη και/ή ανοσοδιαμεσολαβουμενης οστικης απωλειας
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
CY1122429T1 (el) Αμορφη υδροχλωρικη λερκανιδιπινη
CY1114008T1 (el) Θειενοπυριμιδινικες ενωσεις και χρηση τους
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
CY1108729T1 (el) 3,11b-cis-διυδpotetpabenazinh για την θεραπευτικη αντιμετωπιση μιας πολλαπλασιαστικης νοσου ή φλεγμονωδους παθησης
CY1107419T1 (el) Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη
CY1109309T1 (el) Παραγωγα γλυκοπυρανοσυλοξυπυραζολης και χρηση αυτων σε φαρμακευτικα σκευασματα
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
CY1111143T1 (el) Καινοφανη παραγωγα κυανοπυριδινης χρησιμα στην αντιμετωπιση καρκινου και αλλων διαταραχων
ATE538124T1 (de) Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
ATE413388T1 (de) Muskarin antagonisten
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
SE0101932D0 (sv) Pharmaceutical combinations